Thrombolytic Therapy.
出版信息
Br Med J. 1963 Jun 8;1(5344):1492-4.
Abstract
摘要
相似文献
1
Thrombolytic Therapy.
Br Med J. 1963 Jun 8;1(5344):1492-4.
2
[Comparative effectiveness of intracoronary and systemic thrombolytic therapy of acute myocardial infarction].
Kardiologiia. 1989 Aug;29(8):15-9.
3
Aspect of thrombolytic therapy: a review.
ScientificWorldJournal. 2014;2014:586510. doi: 10.1155/2014/586510. Epub 2014 Dec 10.
4
Time as an Adjunctive Agent to Thrombolytic Therapy.
J Thromb Thrombolysis. 1994;1(1):27-34. doi: 10.1007/BF01061992.
5
Thrombolytic therapy and cocaine-associated acute myocardial infarction.
Am J Emerg Med. 2000 Sep;18(5):612-5. doi: 10.1053/ajem.2000.9276.
6
[Thrombolytic therapy of arterial occlusions].
Z Gesamte Inn Med. 1993 Jun-Jul;48(6-7):344-50.
7
Thrombolytic therapy: nursing strategies for successful patient outcomes.
Prog Cardiovasc Nurs. 1995 Winter;10(1):3-12.
8
[Thrombolytic therapy].
Nihon Rinsho. 1998 Oct;56(10):2577-81.
9
QT Dispersion after Thrombolytic Therapy.
Int Cardiovasc Res J. 2014 Dec;8(4):161-5. Epub 2014 Dec 1.
10
Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?
Curr Opin Ophthalmol. 2009 May;20(3):210-8. doi: 10.1097/ICU.0b013e328329b5d5.
本文引用的文献
1
The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.
J Clin Invest. 1959 Sep;38(9):1627-43. doi: 10.1172/JCI103941.
2
Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
Br Med J. 1963 Apr 6;1(5335):915-20. doi: 10.1136/bmj.1.5335.915.
3
Popliteal artery thrombosis treated with streptokinase.
Lancet. 1962 Nov 24;2(7265):1081-3. doi: 10.1016/s0140-6736(62)90786-9.
4
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.
Br Med J. 1963 Apr 6;1(5335):921-3. doi: 10.1136/bmj.1.5335.921.
5
Experience with streptokinase infusions.
Lancet. 1962 Dec 22;2(7269):1297-302. doi: 10.1016/s0140-6736(62)90850-4.
6
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
J Clin Invest. 1962 Apr;41(4):896-916. doi: 10.1172/JCI104546.
7
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
J Clin Invest. 1962 Apr;41(4):917-34. doi: 10.1172/JCI104547.
8
The histological localisation of fibrinolysin activator.
J Pathol Bacteriol. 1959 Jul;78:281-3. doi: 10.1002/path.1700780131.
9
The maintenance of a sustained thrombolytic state in man. I. Induction and effects.
J Clin Invest. 1959 Jul;38(7):1096-110. doi: 10.1172/JCI103886.
10
Fibrinolysis and fibrinolytic activity in man.
Physiol Rev. 1959 Apr;39(2):343-82. doi: 10.1152/physrev.1959.39.2.343.
Zotero 插件